Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Prothrombin time self-testing

This article was originally published in The Gray Sheet

Executive Summary

Payment instructions to local Medicare contractors have been issued, arriving eight months after CMS' coverage decision in September 2001 (1"The Gray Sheet" Oct. 1, 2001, p. 3) and will become effective July 1. Payment levels for procedure code G0249, covering "test materials and equipment," will be released in the July update of the Medicare physician fee schedule...

You may also be interested in...



Prothrombin Tests Win Coverage Battle, But Payment Hurdles Remain

CMS' Sept. 18 coverage decision for prothrombin time self-testing will provide Medicare reimbursement for the disposable test strips, but not the home-use monitoring equipment, according to the Centers for Medicare & Medicaid Services.

Cosmetic And Personal Care Trademark Review 24 November, 2020

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

CBD Health Benefits More Attractive To Women? FDA Prioritizes Research Into Utero Effects

Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA  neuroscientist Andrew Shen.

UsernamePublicRestriction

Register

OM001644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel